Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 1 Interventional

Safety Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Lupus Nephritis

ClinicalTrials.gov ID: NCT01541670

Public ClinicalTrials.gov record NCT01541670. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 25, 2026, 12:38 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Study to Assess the Safety and Tolerability of Anti-MIF Antibody in Subjects With Lupus Nephritis

Study identification

NCT ID
NCT01541670
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 1
Lead sponsor
Baxalta now part of Shire
Industry
Enrollment
4 participants

Conditions and interventions

Interventions

  • Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 27, 2011
Primary completion
Dec 30, 2012
Completion
Dec 30, 2012
Last update posted
May 4, 2021

2011 – 2012

United States locations

U.S. sites
12
U.S. states
8
U.S. cities
10
Facility City State ZIP Site status
Academic Medical Research Institute Inc. Los Angeles California 90022
Mohamed A. El-Shahawy Los Angeles California 90022
North Valley Nephrology Yuba City California 95991
IMMUNOe International Research Centers Centennial Colorado 80112
University of Colorado Denver Colorado 80220
Tulane University Hospital & Clinic New Orleans Louisiana 70112
Clinical Research Development Associates, LLC Springfield Gardens New York 11413
Northeast Clinical Research Center, LLC Bethlehem Pennsylvania 18017
Medical University of South Carolina (MUSC) Charleston South Carolina 29425
Ramesh Gupta Memphis Tennessee 38016
Ramesh Gupta Memphis Tennessee 38119
UT Southwestern Medical Center at Dallas Dallas Texas 75390-8523

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01541670, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 4, 2021 · Synced Jun 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01541670 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →